Immuron Ltd Files 6-K Report
Ticker: IMRN · Form: 6-K · Filed: Jan 15, 2025 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Jan 15, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, filing
TL;DR
Immuron Ltd dropped a 6-K filing on Jan 15, 2025, with two announcements. Details light.
AI Summary
Immuron Limited filed a Form 6-K on January 15, 2025, reporting two published announcements. The filing does not contain specific financial figures or details about the content of these announcements, but indicates the company is a foreign private issuer based in Australia.
Why It Matters
This filing signals ongoing corporate communications from Immuron Ltd to the SEC, which may contain updates relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Immuron Limited (company) — Registrant
- 001-38104 (company) — SEC File Number
- January 2025 (date) — Reporting Period
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have distributed or are required to distribute to their security holders.
What is the filing date of this Form 6-K?
This Form 6-K was filed on January 15, 2025.
Where is Immuron Limited based?
Immuron Limited is based in Carlton South, Victoria, Australia.
Does Immuron Limited file annual reports on Form 20-F?
Yes, Immuron Limited indicates it files annual reports under cover of Form 20-F.
What specific announcements are detailed in this filing?
The filing mentions that Immuron Limited published two announcements, but the content of these announcements is not detailed within the provided text of the 6-K.
Filing Stats: 326 words · 1 min read · ~1 pages · Grade level 18 · Accepted 2025-01-15 08:00:15
Filing Documents
- ea0227739-6k_immuron.htm (6-K) — 13KB
- ea022773901ex99-1_immuron.htm (EX-99.1) — 29KB
- ea022773901ex99-2_immuron.htm (EX-99.2) — 38KB
- ex99-1_001.jpg (GRAPHIC) — 17KB
- ex99-1_002.jpg (GRAPHIC) — 42KB
- ex99-2_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-003622.txt ( ) — 166KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of January 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on January 15, 2025 titled: - “Immuron Announces Monash AMR Research Collaboration” - “Proposed issue of securities – IMC” A copy of the Public Notices are attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron Announces Monash AMR Research Collaboration 99.2 Proposed issue of securities - IMC 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: January 15, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3